Tous Actualités
Suivre
Abonner Solianis Monitoring AG

Solianis Monitoring AG

Long-term investment secured - Swiss foundation supports innovative concept for patients with diabetes

Zurich (ots)

Solianis recently signed an investment agreement
with a Swiss foundation which invests its assets in Swiss companies. 
According to the agreement, this foundation will put CHF 5 million, 
while the previous investors in Solianis are investing another CHF 3 
million.
"The CHF 8 million invested will enable us to increase our efforts
to complete the prototype of our non-invasive glucose monitoring 
device and to prepare the clinical trials required for CE 
certification. The realisation of our innovative product concept is 
now assured", says Mario Stark, managing director at Solianis.
Dr. Andreas Bänziger, member of Solianis' Board of Directors, 
confirms that "Solianis convinced the foundation with its technology,
successful tests and expert team. Together with former and new 
investors we will implement our project and are able to take the 
steps necessary to be ready for market introduction".
Solianis Monitoring AG is a medical devices company developing a 
non-invasive Continuous Glucose Monitor (CGM) for self-monitoring 
patients with diabetes. Its technology is based on a unique and 
proprietary multisensor technology for monitoring physiological 
parameters. Solianis' non-invasive device delivers comparable results
to the minimally invasive devices currently approved by the 
FDA
Solianis was incorporated in May 2005, and is funded by private 
investors and the Pioneer Fund of the Cantonal Bank of Zürich. The 
company plans to introduce its first-generation device for 
insulin-dependent patients with diabetes by 2010 in Europe, after CE 
approval. Later product generations will target all patients with 
diabetes and impaired glucose tolerance.

Contact:

Solianis Monitoring AG
Mario Stark
Tel.: +41/44/306'80'40
Mobile: +41/79/542'88'74
E-Mail: mario.stark@solianis.com
Internet: http://www.solianis.com

Plus de actualités: Solianis Monitoring AG
Plus de actualités: Solianis Monitoring AG
  • 26.02.2009 – 11:07

    Scientific Recognition for Solianis based on Successful Tests

    Zurich, Swizerland (ots) - Recently, Solianis successfully finalized a series of tests during which patients with diabetes have worn its multisensor device for non-invasive glucose monitoring at home and at work in the office. The results of these real-life tests as well as earlier tests in a more controlled environment have encouraged Solianis to set up the final device and prepare the market introduction for 2010. ...

  • 13.10.2008 – 10:00

    Convincing results of Solianis' multisensor system in home-use trial

    Zurich, (ots) - Solianis' multisensor system for non-invasive Continuous Glucose Monitoring is currently being tested by diabetic patients in the home and work environment. 12 patients have completed a 10-day trial aimed at assessing system reliability. Results indicate that the system tracks glucose in home-use settings and is sensitive to hypoglycemic glucose ...